摘要:
The present invention relates to a novel dosage form, to a process for preparing the dosage form and to the use of the dosage form in the treatment of neurological and psychiatric disorders.
摘要:
The present invention relates to a new molecular pathway in which activation of the receptor-interacting protein (RIP, a serine-threonine kinase) and Jun N-terminal kinase induce cell death with the morphology of autophagy. Further, autophagic death is induced by caspase 8 inhibition and expression of the mammalian genes ATG7 and beclin.
摘要:
The invention discloses newly-discovered phosphorylation sites in human IRS-1 and IRS-2, serine 1101 (Ser1101) and serine 1149 (Ser1149) respectively, and provides antibodies, both polyclonal and monoclonal, that selectively bind to IRS-1 and/or IRS-2 when phosphorylated at these respective sites, but do not bind to IRS-1 and/or IRS-2 when not phosphorylated at these respective sites. The sites are relevant to insulin-resistance in type 2 diabetes. Also provided are methods for determining the phosphorylation of IRS-1/2 or activity of PKC theta in a biological sample, by using a detectable reagent, such as the disclosed antibodies, that binds to IRS-1/2 only when phosphorylated at Ser1101/Ser1149. Kits comprising the phosphor-IRS-1/2 (Ser1101/1149) antibodies of the invention are also provided.
摘要:
The invention discloses 318 novel phosphorylation sites identified in carcinoma, peptides (including AQUA peptides) comprising a phosphorylation site of the invention, antibodies specifically bind to a novel phosphorylation site of the invention, and diagnostic and therapeutic uses of the above.
摘要:
The invention discloses novel phosphorylation sites identified in carcinoma and/or leukemia, peptides (including AQUA peptides) comprising a phosphorylation site of the invention, antibodies specifically bind to a novel phosphorylation site of the invention, and diagnostic and therapeutic uses of the above.
摘要:
The invention discloses 322 novel acetylation sites identified in various cancers, peptides (including AQUA peptides) comprising a acetylation site of the invention, antibodies specifically bind to a novel acetylation site of the invention, and diagnostic and therapeutic uses of the above.
摘要:
A method for measuring pole width of a slider of a disk drive includes steps of: getting an original image of the pole surface; calculating the light intensity distribution profile of the original image and determining maximum and minimum light intensity data points of the profile; setting average of the maximum and minimum light intensity data points as a threshold; carrying out quadratic differentiation of the profile to obtain a quadratic differential asymptote; determining cross points between the quadratic differential asymptote and the threshold; calculating the distance between the cross points to obtain an initial pole width; and performing data compensation to the initial pole width to obtain a compensated pole width. The method may also measure the distance between edges of other micro-objects.
摘要:
An encoding method and an encoder for encoding data transmitted in a manner of bursts via a parallel bus and a decoding method and a decoder. The encoding method includes organizing data of the bursts into matrixes, determining for each of the matrixes whether a transform mode capable of decreasing the bus transition number exists, determining that the matrix needs to be transformed, determining a transform mode for transforming the matrix, and replacing the initial matrix with the transformed matrix. Then, forming a new matrix to be transmitted from matrixes which do not need to be transformed and matrixes which have been transformed. Thereafter, first generating a transform information word indicating transform states of the respective matrixes and then attaching the transform information word to the matrix to be transmitted to form an encoded matrix for actual transmission.
摘要:
The invention discloses 405 novel phosphorylation sites identified in carcinoma and/or leukemia, peptides (including AQUA peptides) comprising a phosphorylation site of the invention, antibodies specifically bind to a novel phosphorylation site of the invention, and diagnostic and therapeutic uses of the above.
摘要:
Embodiments of the subject invention can involve a method of suppressing noise in hemodynamic deconvolution for event-related functional MR imaging (ER-fMRI). A typical ER-fMRI experiment measures the Blood Oxygenation Level Dependent (BOLD) response to a series of sparse, short-duration stimuli. Based on the deconvolution of a hemodynamic response function (HRF) from the BOLD signal and event stimulus function, the neuronal activation can be localized to specific brain regions and tracked on the order of a second. ER-fMRI can be used to study the temporal dynamics of neuronal network. However, in certain situations, aliasing noise can be generated in hemodynamic deconvolution due to the low sampling rate limited by the imaging speed. This aliasing noise can reduce the accuracy of temporal characterization of the HRF. In an embodiment, by incorporating the use of a phantom having one or more coil loops positioned perpendicular to the magnetic field Bo, such that DC current inputted into one of the loops will produce field distortion to Bo, an ER-fMRI experiment can be calibrated and the temporal measurement of HRF can be improved with the removal of aliasing noise.